1. Home
  2. SAIC vs PTCT Comparison

SAIC vs PTCT Comparison

Compare SAIC & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

SAIC

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

N/A

Current Price

$150.74

Market Cap

5.4B

Sector

Technology

ML Signal

N/A

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

N/A

Current Price

$63.60

Market Cap

5.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SAIC
PTCT
Founded
1969
1998
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
5.0B
IPO Year
2013
2006

Fundamental Metrics

Financial Performance
Metric
SAIC
PTCT
Price
$150.74
$63.60
Analyst Decision
Hold
Buy
Analyst Count
10
15
Target Price
★ $132.56
$100.47
AVG Volume (30 Days)
362.9K
★ 1.0M
Earning Date
12-03-2026
10-29-2026
Dividend Yield
★ 0.98%
N/A
EPS Growth
7.39
★ 264.48
EPS
★ 5.00
0.34
Revenue
★ $7,262,000,000.00
$264,734,000.00
Revenue This Year
$0.49
N/A
Revenue Next Year
$1.38
$8.29
P/E Ratio
★ $30.19
$187.03
Revenue Growth
N/A
★ 36.19
52 Week Low
$81.08
$58.80
52 Week High
$155.11
$90.87

Technical Indicators

Market Signals
Indicator
SAIC
PTCT
Relative Strength Index (RSI) 62.07 47.73
Support Level $122.58 $60.16
Resistance Level $155.11 $63.74
Average True Range (ATR) 5.36 2.69
MACD -0.36 0.09
Stochastic Oscillator 66.71 36.62

Price Performance

Historical Comparison
SAIC
PTCT

About SAIC SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

Science Applications International Corp provides technical, engineering, and enterprise IT services mainly to the U.S. government. Specifically, it offers end-to-end solutions spanning the design, development, integration, deployment, management, operations, sustainment, and security of the customer's entire IT infrastructure. The company has two reportable segments, which include Defense and Intelligence and the Civilian segment. Maximum revenue is generated from its Defense and Intelligence segment, which provides a diverse portfolio of national security solutions to the DoW and the Intelligence Community of the United States Government. The Civilian segment provides solutions to the civilian markets, encompassing federal, state, and local governments.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Share on Social Networks: